These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 1919091)

  • 1. Relapse in leprosy after multidrug therapy and its differential diagnosis with reversal reaction.
    Reddy PK; Cherian A
    Indian J Lepr; 1991; 63(1):61-9. PubMed ID: 1919091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
    de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reactions in borderline leprosy.
    Ramu G; Desikan KV
    Indian J Lepr; 2002; 74(2):115-28. PubMed ID: 12708730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Occurrence of reactions, their diagnosis and management in leprosy patients treated with multidrug therapy; experience in the leprosy control program of the All Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia.
    Becx-Bleumink M; Berhe D
    Int J Lepr Other Mycobact Dis; 1992 Jun; 60(2):173-84. PubMed ID: 1522359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histological assessment of dermal nerve damage occurring during multidrug therapy for leprosy.
    Jain M; Singh N; Bhatia A; Arora VK
    Int J Lepr Other Mycobact Dis; 2000 Jun; 68(2):167-71. PubMed ID: 11036497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase 2 open trial of pentoxifylline for the treatment of leprosy reactions.
    Dawlah ZM; Cabrera A; Ahern K; Levis WR
    Int J Lepr Other Mycobact Dis; 2002 Mar; 70(1):38-43. PubMed ID: 12120041
    [No Abstract]   [Full Text] [Related]  

  • 7. Incidence of late lepra reaction among multibacillary leprosy patients after MDT.
    Vijayakumaran P; Manimozhi N; Jesudasan K
    Int J Lepr Other Mycobact Dis; 1995 Mar; 63(1):18-22. PubMed ID: 7730714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relapses in paucibacillary leprosy after MDT--a clinical study.
    Grugni A; Nadkarni NJ; Kini MS; Mehta VR
    Int J Lepr Other Mycobact Dis; 1990 Mar; 58(1):19-24. PubMed ID: 2319185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphocyte proliferation, IFN-gamma production and limiting dilution analysis of T-cell responses to ICRC and Mycobacterium leprae antigens in leprosy patients.
    Shinde SR; Chiplunkar SV; Butlin R; Samson PD; Deo MG; Gangal SG
    Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):51-8. PubMed ID: 8326181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal reaction, nerve damage and steroid therapy in three multibacillary HIV positive patients.
    Arunthathi S; Ebenezer L; Kumuda C
    Lepr Rev; 1998 Jun; 69(2):173-7. PubMed ID: 9715603
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of drug treatment on electroneurological measures of peripheral nerve function in leprosy patients.
    Mendis S; Somasiri KG; Chularatna W
    Ceylon Med J; 1993 Dec; 38(4):174-7. PubMed ID: 8143332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Occurrence and management of leprosy reaction in China in 2005.
    Shen J; Liu M; Zhou M; Wengzhong L
    Lepr Rev; 2009 Jun; 80(2):164-9. PubMed ID: 19743620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silent iritis in treated bacillary negative leprosy.
    Thompson K; Job CK
    Int J Lepr Other Mycobact Dis; 1996 Sep; 64(3):306-10. PubMed ID: 8862265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Borderline lepromatous leprosy presenting as a single cutaneous plaque.
    Armour KS; Scolyer RA; Barnetson RS
    Australas J Dermatol; 2005 Aug; 46(3):181-3. PubMed ID: 16008652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New lesions after MDT in PB and MB leprosy: a report of 28 cases.
    Kar HK; Sharma P
    Indian J Lepr; 2008; 80(3):247-55. PubMed ID: 19432355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An investigation of mast cells in two basic leprosy groups.
    Aroni K; Kontochristopoulos G; Liossi A; Panteleos D
    Int J Lepr Other Mycobact Dis; 1993 Dec; 61(4):634-5. PubMed ID: 8151199
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical features and outcome of reversal (type 1) reactions in Hyderabad, India.
    Lockwood DN; Vinayakumar S; Stanley JN; McAdam KP; Colston MJ
    Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):8-15. PubMed ID: 8326184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of relapse with drug-susceptible M. leprae after multidrug therapy.
    Constant-Desportes M; Guelpa-Lauras CC; Carolina JC; Léoture A; Grosset JH; Sansarricq H
    Int J Lepr Other Mycobact Dis; 1991 Jun; 59(2):242-7. PubMed ID: 2071981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical assessment of paucibacillary leprosy under multidrug therapy-three years followup study.
    Revankar CR; Karjivkar VG; Gurav VJ; Ganapati R
    Indian J Lepr; 1989 Jul; 61(3):355-9. PubMed ID: 2768883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two microbiological relapses in a patient with lepromatous leprosy.
    Chakma JK; Girdhar A; Natrajan M; Kumar A; Girdhar BK
    Lepr Rev; 2008 Sep; 79(3):331-4. PubMed ID: 19009984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.